A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation

被引：0
作者：
Jin Xu
Dapeng Zhang
Rongji Mu
机构：
[1] School of Statistics,
[2] East China Normal University,undefined
[3] Key Laboratory of Advanced Theory and Application in Statistics and Data Science - MOE,undefined
[4] East China Normal University,undefined
[5] Clinical Research Center,undefined
[6] Shanghai Jiao Tong University School of Medicine,undefined
来源：
BMC Medical Research Methodology | / 22卷
关键词：
Adaptive design; Dose-finding; Maximum tolerated dose; Stochastic approximation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 71 条
[21]  
Gsponer T(1997)Accelerated titration designs for phase I clinical trials in oncology J Natl Cancer Inst. 89 1138-57
[22]  
Ji Y(2014)A Bayesian dose-finding design for drug combination clinical trials based on the logistic model Pharm Stat. 13 247-34
[23]  
Liu P(2021)Incorporating historical information to improve phase I clinical trial designs Pharm Stat. 20 1017-304
[24]  
Li Y(2020)The i3+3 design for phase I clinical trials J Biopharm Stat. 30 294-91
[25]  
Bekele BN(2013)Modified toxicity probability interval design: a safer and more reliable method than the 3+ 3 design for practical phase I trials J Clin Oncol. 31 1785-undefined
[26]  
Guo W(undefined)undefined undefined undefined undefined-undefined
[27]  
Wang SJ(undefined)undefined undefined undefined undefined-undefined
[28]  
Yang S(undefined)undefined undefined undefined undefined-undefined
[29]  
Lynn H(undefined)undefined undefined undefined undefined-undefined
[30]  
Ji Y(undefined)undefined undefined undefined undefined-undefined
12345678